The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder

• Conditions: Enuresis; Attention Deficit Hyperactivity Disorder

• Registration Number: NCT02699528
• Lead Sponsor: Meir Medical Center

Brief Summary

To assess wether methylphenidate reduces the prevalence of primary nocturnal enuresis in children with attention deficit disorder

Detailed Description

Children aged 5 - 10 years newly diagnosed with attention deficit hyperactivity disorder who report primary nocturnal enuresis, Investigators will obtain baseline data (from parents/caregivers) on their sleep habits and enuresis characteristics by questionnaire. After 6 weeks of methylphenidate therapy, prescribed for the attention deficit, a new questionnaire will be filled.

Study Timeline

• Study First Submitted: 2016-02-02
• Study First Submitted QC: 2016-03-03
• Study First Posted: 2016-03-04
• Study Start: 2016-05
• Status Verified: 2016-09
• Last Update Submitted: 2016-09-15
• Last Update Posted: 2016-09-16
• Primary Completion: 2017-04
• Study Completion: 2017-05

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• New diagnosis of attention deficit hyperactivity disorder
• History of primary nocturnal enuresis
• Normal neurological examination

Exclusion Criteria

• Anatomical abnormality of the genitourinary system
• Concommitant treatment, pharmacological/behavioral for enuresis
• Concommitant diurnal enuresis

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
A reduction in nocturnal enuresis frequency	6 weeks

Trial Locations

Locations (1)

Meir Medical Center; 🇮🇱 Kfar Saba, Israel